Dr. Jorge Santos da Silva

Dr. Jorge Santos da Silva

Chief Executive Officer and Interim Chair of the BoardatMoonLake Immunotherapeutics· In proxies 2022–2025

Pay in FY2025+252% from the year before · MoonLake Immunotherapeutics stock -75.7% the same year

Dr. Jorge Santos da Silva was paid $4.9M in FY2025 (Dec), up 252%. MoonLake Immunotherapeutics stock fell 75.7% that year.

Pay$100 in the stock at the end of FY21 → $133
Pay is from the Summary Compensation Table of each MoonLake Immunotherapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. MoonLake ImmunotherapeuticsPublic company · 4 yr
    • Chief Executive Officer and Interim Chair of the Board2022 – Present · 4 yrStock in role +24%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?